Fatal melanoma with a novel MYO5A-BRAF fusion and small associated conventional nevus: A case report and review of literature

J Cutan Pathol. 2022 Sep;49(9):808-812. doi: 10.1111/cup.14263. Epub 2022 Jun 12.

Abstract

Kinase fusions play an important role in the pathogenesis of Spitz neoplasms and occasionally non-Spitz neoplasms. We report a case of a 19-year-old woman with a growing nodule on the scalp, morphologically consistent with a diagnosis of melanoma with epithelioid features arising in association with small nevus. This tumor aggressively metastasized and failed to respond to immunotherapy. Next-generation sequencing of a metastatic focus revealed an MYO5A-BRAF kinase fusion with a low mutational burden and fluorescence in situ hybridization (FISH) of the primary melanoma showed similar results. FISH testing of the associated nevus failed because of technical reasons. MYO5A has rarely been reported as the fusion partner with BRAF-rearranged melanocytic tumors. Moreover, this case raises speculations and contributes to the growing literature on the pathogenesis, nomenclature, and tumorigenic pathways in kinase-fusion melanomas. The patient succumbed to disease, which is in concordance with some literature suggesting aggressive behavior of BRAF fusion melanomas with TERT promoter mutations.

Keywords: Spitz melanoma; TERT-promoter mutation; genomic analysis; kinase-fusion mutation; spitzoid neoplasm.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Humans
  • In Situ Hybridization, Fluorescence
  • Melanoma* / pathology
  • Myosin Heavy Chains / genetics
  • Myosin Type V* / genetics
  • Nevus, Epithelioid and Spindle Cell*
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms* / pathology

Substances

  • MYO5A protein, human
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Myosin Type V
  • Myosin Heavy Chains